INSP — Inspire Medical Systems, Inc.
—
NYSE ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1609550 ·
Last close
$61.47
Market Cap
$1.78B
52W High
$66.21
52W Low
$38.91
ADV30
740,615
Next earnings
2026-11-02
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 200,581,000 | 171,459,000 | -514,000 | 314,000 | 925,993,000 | 127,761,000 | 100,411,000 |
| Mar 2026 | 204,583,000 | 176,912,000 | -1,118,000 | -11,294,000 | 911,376,000 | 98,932,000 | 119,036,000 |
| Dec 2025 | 269,077,000 | 233,006,000 | 46,111,000 | 136,090,000 | 907,317,000 | 104,813,000 | 126,157,000 |
| Sep 2025 | 224,501,000 | 192,728,000 | 9,644,000 | 9,932,000 | 807,716,000 | 112,845,000 | 141,256,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$157,072,000
Investing CF
$-31,264,000
Financing CF
$-104,957,000
CapEx
$-39,981,000
Dividends Paid
—
Buybacks
$-100,010,000
EPS Diluted TTM
$4.62
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-157,472,000
Inventory
$170,451,000
Receivables
$103,340,000
ST Investments
$192,923,000
EBIT TTM
$62,371,000
Pretax Income TTM
$69,382,000
Interest Exp TTM
$137,000
Analysts
15
Yahoo Snapshot (yfinance, live)
Total Revenue
$898,742,016
EBITDA
$71,329,000
Free Cash Flow
$94,637,248
Enterprise Value
$1,485,529,728
Total Cash
$320,684,000
Total Debt
$29,093,000
Shares Out
28,910,375
Trailing EPS
$4.46
Book Value
$28.56
ROE
18.0%
ROA
3.9%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 911,981,000 | 50,954,000 | 145,422,000 | 907,317,000 | 126,157,000 | — | 116,976,000 |
| Dec 2024 | 802,804,000 | 36,083,000 | 53,509,000 | 808,383,000 | 118,688,000 | — | 130,246,000 |
| Dec 2023 | 624,799,000 | -40,271,000 | -21,153,000 | 676,811,000 | 104,297,000 | — | 24,653,000 |
| Dec 2022 | 407,856,000 | -47,592,000 | -44,881,000 | 564,876,000 | 68,868,000 | — | 11,569,000 |
TTM Snapshot
Revenues TTM
$527,366,000
NetIncome TTM
$-22,953,000
OpCashFlow TTM
$0
Assets (Latest)
$808,383,000
Forward EPS
$1.54
Max Pain — expiry 2026-09-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $50.00 · spot: $61.47 · call volume: 24 · put volume: 211
Expected Move to 2026-09-18:
±$4.22
(6.87%) —
implied range
$57.25 –
$65.69
· ATM straddle on $60.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BLFS | BIOLIFE SOLUTIONS INC | $1.82B | $37.19 | — |
| LMAT | LEMAITRE VASCULAR INC | $1.83B | $79.96 | — |
| NVCR | NovoCure Ltd | $1.95B | $16.76 | — |
| KMTS | KESTRA MEDICAL TECHNOLOGIES, LTD. | $1.58B | $26.91 | — |
| TNDM | TANDEM DIABETES CARE INC | $1.55B | $22.22 | — |
News headlines (Yahoo Finance, 1h cache)
INSP Stock Rallies Nearly 40% YTD: Can Its Growth Story Continue?
2026-08-21 15:34 · Yahoo
Here's Why You Should Add INSP Stock to Your Portfolio Now
2026-08-20 16:19 · Yahoo
Which Medtech Giant Would Buy Inspire Medical Systems?
2026-08-14 21:54 · Yahoo
Inspire Medical Systems (INSP) Q2 2026 Earnings Call Transcript
2026-08-11 01:58 · Yahoo
Is INSP a Buy as Margins Improve but Reimbursement Risks Persist?
2026-08-05 17:59 · Yahoo
Inspire Medical Q2 Earnings Beat Estimates, '26 View Raised, Stock Up
2026-08-04 16:58 · Yahoo
INSP's 28.1% Past-Month Rally Raises a Key Question for Investors
2026-08-05 17:35 · Yahoo
3 Cash-Producing Stocks That Concern Us
2026-08-25 09:18 · Yahoo
1 Unpopular Stock That Deserves Some Love and 2 We Avoid
2026-08-24 07:21 · Yahoo
1 Healthcare Stock for Long-Term Investors and 2 Facing Challenges
2026-08-20 12:59 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.